Auraphene-b

Auraphene-b Medicine

Overdose

Intoxication after applying Aurvana In unknown and is not expected due to the composition of the drug. Skin irritation caused by an overdose quickly passes after stopping taking the drug.

Contraindications

The drug should not be widely used in patients with severe renal insufficiency.

Incompatibilities

The.

Undesirable effects

Skin and subcutaneous tissue

Possible hypersensitivity reactions to the ingredients or skin irritation in the treatment of acute inflammatory skin diseases.

During the post-marketing follow-up, erythema, burning sensation of the skin and itching were reported.

Treatment should be discontinued in case of erythema, burning sensation of the skin, itching, rash or hypersensitivity reactions after the use of the drug.

Report of suspected adverse reactions

It is important to report suspicious adverse reactions after obtaining approval for the use of the drug. This allows you to continue monitoring the benefit/risk balance of the drug. Health professionals are asked to report any suspicious adverse reactions using the Yellow Card Scheme. Web site: www.mhra.gov.uk/yellowcard

Preclinical safety data

No specific information is provided, given the widespread use of topical urea in humans for many years.

Therapeutic indications

Softening, moisturizing and protective cream for dry or damaged skin

Pharmacotherapeutic group

Protective and emollient agents.

Pharmacodynamic properties

Pharmacotherapeutic group: Protective and emollient agents.

ATC Code: D02 AE01

Urea is a recognized moisturizing agent that is widely used topically to treat dry or damaged skin.

Pharmacokinetic properties

The. Aurafin-To-local (skin) drug.

Name of the medicinal product

Aurafin-B

Qualitative and quantitative composition

Urea Peroxide

Special warnings and precautions for use

Avoid contact with eyes and mucous membranes. If irritation occurs, temporarily stop taking the drug and consult your doctor.

Apply with caution only on damaged or inflamed skin or on the face.

The drug should be used under the supervision of a doctor in infants.

Effects on ability to drive and use machines

Auraphene-B has no or negligible effect on the ability to drive and operate machinery.

Dosage (Posology) and method of administration

Adults, children, and the elderly

Apply evenly to dry skin two to three times a day or as directed by your doctor or pharmacist.

Special precautions for disposal and other handling

No special requirements.

Any unused medicinal product or waste must be disposed of in accordance with local regulations.